DK0533845T3 - Anvendelse af 5,10,15,20-tetrakis(r-carboxyphenyl)porphin til detektion og behandling af lungecancer - Google Patents
Anvendelse af 5,10,15,20-tetrakis(r-carboxyphenyl)porphin til detektion og behandling af lungecancerInfo
- Publication number
- DK0533845T3 DK0533845T3 DK91913465T DK91913465T DK0533845T3 DK 0533845 T3 DK0533845 T3 DK 0533845T3 DK 91913465 T DK91913465 T DK 91913465T DK 91913465 T DK91913465 T DK 91913465T DK 0533845 T3 DK0533845 T3 DK 0533845T3
- Authority
- DK
- Denmark
- Prior art keywords
- porphine
- carboxyphenyl
- tetrakis
- treatment
- radiotracer
- Prior art date
Links
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- JZRYQZJSTWVBBD-UHFFFAOYSA-N pentaporphyrin i Chemical compound N1C(C=C2NC(=CC3=NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 JZRYQZJSTWVBBD-UHFFFAOYSA-N 0.000 title 1
- 239000000700 radioactive tracer Substances 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 210000004072 lung Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000005855 radiation Effects 0.000 abstract 2
- HHDUMDVQUCBCEY-UHFFFAOYSA-N 4-[10,15,20-tris(4-carboxyphenyl)-21,23-dihydroporphyrin-5-yl]benzoic acid Chemical compound OC(=O)c1ccc(cc1)-c1c2ccc(n2)c(-c2ccc(cc2)C(O)=O)c2ccc([nH]2)c(-c2ccc(cc2)C(O)=O)c2ccc(n2)c(-c2ccc(cc2)C(O)=O)c2ccc1[nH]2 HHDUMDVQUCBCEY-UHFFFAOYSA-N 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- RYGMFSIKBFXOCR-IGMARMGPSA-N copper-64 Chemical compound [64Cu] RYGMFSIKBFXOCR-IGMARMGPSA-N 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 238000010191 image analysis Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000036210 malignancy Effects 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 238000002600 positron emission tomography Methods 0.000 abstract 1
- 238000002603 single-photon emission computed tomography Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1206—Administration of radioactive gases, aerosols or breath tests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/80—Fluorescent dyes, e.g. rhodamine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Atmospheric Sciences (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/539,999 US5162231A (en) | 1989-10-25 | 1990-06-15 | Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung |
| PCT/US1991/004132 WO1991019977A1 (en) | 1990-06-15 | 1991-06-17 | USING 5,10,15,20-TETRAKIS(r-CARBOXYPHENYL)PORPHINE FOR DETECTING AND TREATING LUNG CANCER |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0533845T3 true DK0533845T3 (da) | 2004-02-16 |
Family
ID=24153544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91913465T DK0533845T3 (da) | 1990-06-15 | 1991-06-17 | Anvendelse af 5,10,15,20-tetrakis(r-carboxyphenyl)porphin til detektion og behandling af lungecancer |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US5162231A (da) |
| EP (1) | EP0533845B1 (da) |
| JP (1) | JP3047468B2 (da) |
| KR (1) | KR0171393B1 (da) |
| AT (1) | ATE251750T1 (da) |
| AU (2) | AU8061491A (da) |
| BR (1) | BR9106563A (da) |
| CA (1) | CA2085464C (da) |
| DE (1) | DE69133325T2 (da) |
| DK (1) | DK0533845T3 (da) |
| FI (1) | FI925673A (da) |
| HU (1) | HUT63499A (da) |
| NO (1) | NO924820L (da) |
| RU (1) | RU2114430C1 (da) |
| WO (2) | WO1991019978A1 (da) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622685A (en) * | 1990-05-30 | 1997-04-22 | Deutches Krebsforchunszentrum Stiftung Des Offentlichen Rechts | Polyether-substituted porphyrin anti-tumor agents |
| US5252698A (en) * | 1992-10-09 | 1993-10-12 | Sri International | Metal ion porphyrin-containing poly(azine) |
| US5464741A (en) * | 1993-10-08 | 1995-11-07 | Henwell, Inc. | Palladium (II) octaethylporphine alpha-isothiocyanate as a phosphorescent label for immunoassays |
| US6490330B1 (en) * | 1994-04-12 | 2002-12-03 | The Regents Of The University Of California | Production of high specific activity copper -67 |
| US5716958A (en) * | 1994-10-27 | 1998-02-10 | Tobishi Pharmaceutical Co., Ltd. | Amino acid derivative having anti-CCK activity |
| US5756726A (en) * | 1995-06-02 | 1998-05-26 | Pharmacyclics, Inc. | Methods of producing singlet oxygen using compounds having improved functionalization |
| AU737650B2 (en) | 1997-11-03 | 2001-08-23 | Duke University | Substituted porphyrins |
| US6703050B1 (en) * | 1998-09-04 | 2004-03-09 | The Regents Of The University Of Michigan | Methods and compositions for the prevention or treatment of cancer |
| ATE552260T1 (de) | 1999-01-25 | 2012-04-15 | Nat Jewish Health | Substituierte porphyrine und deren therapeutische verwendung |
| US6984498B2 (en) * | 1999-12-27 | 2006-01-10 | Adair Edwin L | Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques |
| US6190877B1 (en) * | 1999-12-27 | 2001-02-20 | Edwin L. Adair | Method of cancer screening primarily utilizing non-invasive cell collection and fluorescence detection techniques |
| US6750037B2 (en) * | 1999-12-27 | 2004-06-15 | Edwin L. Adair | Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques |
| US6575888B2 (en) * | 2000-01-25 | 2003-06-10 | Biosurface Engineering Technologies, Inc. | Bioabsorbable brachytherapy device |
| KR100390771B1 (ko) * | 2000-08-31 | 2003-07-10 | 한국화학연구원 | 광역학 치료(ｐｄｔ)용 광민감성 물질로 유용한 포르피린유도체 |
| DK1364044T3 (da) | 2000-11-17 | 2012-05-07 | Biomoda Inc | Sammensætninger og fremgangsmåder til påvisning af præcancerøse tilstande i celle- og vævsprøver under anvendelse af 5,10,15,20-tetrakis(carboxyphenyl)porphin |
| AU2002248366B2 (en) | 2001-01-19 | 2006-10-26 | Aeolus Sciences, Inc. | Cancer therapy |
| AU2002312194B8 (en) | 2001-06-01 | 2008-05-15 | Aeolus Sciences, Inc. | Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
| US6566517B2 (en) | 2001-06-06 | 2003-05-20 | Brookhaven Science Associates, Llc | Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy |
| EP1487983A4 (en) * | 2002-03-01 | 2007-08-15 | Sloan Kettering Inst Cancer | PREVENTING THE REPEAT AND METASTASIS OF CANCER |
| CA2488500A1 (en) | 2002-06-07 | 2003-12-18 | Duke University | Substituted porphyrins |
| ATE336266T1 (de) * | 2002-06-21 | 2006-09-15 | Adair Edwin Lloyd | Anwendung von metalloporphyrinen zur behandlung von arteriosklerose |
| JP2005538093A (ja) | 2002-07-23 | 2005-12-15 | ザ リージェンツ オブ ザ ユニバーシティー オブ ミシガン | 抗血管形成療法のための、テトラポリアンモニウムテトラチオモリブデートおよび関連化合物 |
| US20070149496A1 (en) * | 2003-10-31 | 2007-06-28 | Jack Tuszynski | Water-soluble compound |
| US6989443B2 (en) * | 2004-06-28 | 2006-01-24 | Brookhaven Science Associates, Llc | Carboranylporphyrins and uses thereof |
| US6995260B2 (en) * | 2004-05-20 | 2006-02-07 | Brookhaven Science Associates, Llc | Carboranylporphyrins and uses thereof |
| US20060094682A1 (en) * | 2004-10-29 | 2006-05-04 | Odyssey Thera, Inc. | Kinase inhibitors for the treatment of diabetes and obesity |
| CA2651994C (en) * | 2006-05-17 | 2016-04-19 | Koninklijke Philips Electronics N.V. | Retrospective sorting of 4d ct into breathing phases based on geometric analysis of imaging fiducials |
| US9957293B2 (en) * | 2006-08-23 | 2018-05-01 | Yeda Research And Development Company Ltd. | Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| US8287839B2 (en) * | 2006-12-04 | 2012-10-16 | Brookhaven Science Associates, Llc | Carboranylporphyrins and uses thereof |
| US8444953B2 (en) * | 2007-03-22 | 2013-05-21 | Brookhaven Science Associates, Llc | Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof |
| US20080279781A1 (en) * | 2007-05-10 | 2008-11-13 | Brookhaven Science Associates, Llc | Glycosylated Carboranylporphyrins and Uses Thereof |
| RU2506083C2 (ru) | 2008-05-23 | 2014-02-10 | Нэшнл Джуиш Хелт | Способ лечения поражений, ассоциированных с воздействием алкилирующих веществ |
| ES2651068T3 (es) * | 2009-07-17 | 2018-01-24 | Bioaffinity Technologies, Inc. | Sistema y procedimiento de análisis de muestras marcadas con 5,10,15,20 tetraquis(4 carboxifenil)porfirina (TCPP) |
| MX2018015916A (es) | 2016-06-16 | 2019-03-28 | Oncoselect Therapeutics Llc | Compuestos de porfirina y composiciones útiles para el tratamiento de cáncer. |
| CN107589189B (zh) * | 2017-09-06 | 2018-07-10 | 中国农业科学院饲料研究所 | 一种氟甲喹的手性对映体的检测方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4930516B1 (en) * | 1985-11-13 | 1998-08-04 | Laser Diagnostic Instr Inc | Method for detecting cancerous tissue using visible native luminescence |
| US4783529A (en) * | 1985-12-03 | 1988-11-08 | Research Corporation Technologies | Rapid synthesis of radiolabeled porphyrin complexes for medical application |
| US4857300A (en) * | 1987-07-27 | 1989-08-15 | Cytocorp, Inc. | Cytological and histological fixative formulation and methods for using same |
-
1990
- 1990-06-15 US US07/539,999 patent/US5162231A/en not_active Expired - Lifetime
-
1991
- 1991-06-14 AU AU80614/91A patent/AU8061491A/en not_active Abandoned
- 1991-06-14 WO PCT/US1991/004267 patent/WO1991019978A1/en unknown
- 1991-06-17 CA CA002085464A patent/CA2085464C/en not_active Expired - Fee Related
- 1991-06-17 EP EP91913465A patent/EP0533845B1/en not_active Expired - Lifetime
- 1991-06-17 DE DE69133325T patent/DE69133325T2/de not_active Expired - Fee Related
- 1991-06-17 AT AT91913465T patent/ATE251750T1/de not_active IP Right Cessation
- 1991-06-17 JP JP3512285A patent/JP3047468B2/ja not_active Expired - Fee Related
- 1991-06-17 DK DK91913465T patent/DK0533845T3/da active
- 1991-06-17 KR KR1019920703213A patent/KR0171393B1/ko not_active IP Right Cessation
- 1991-06-17 WO PCT/US1991/004132 patent/WO1991019977A1/en active IP Right Grant
- 1991-06-17 BR BR919106563A patent/BR9106563A/pt not_active IP Right Cessation
- 1991-06-17 HU HU923923A patent/HUT63499A/hu unknown
- 1991-06-17 AU AU81906/91A patent/AU670743B2/en not_active Ceased
- 1991-06-17 RU RU92016479A patent/RU2114430C1/ru not_active IP Right Cessation
-
1992
- 1992-07-15 US US07/914,376 patent/US5391547A/en not_active Expired - Lifetime
- 1992-12-14 NO NO92924820A patent/NO924820L/no unknown
- 1992-12-14 FI FI925673A patent/FI925673A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU8061491A (en) | 1992-01-07 |
| AU8190691A (en) | 1992-01-07 |
| RU2114430C1 (ru) | 1998-06-27 |
| EP0533845B1 (en) | 2003-10-08 |
| CA2085464A1 (en) | 1991-12-16 |
| DE69133325T2 (de) | 2004-07-29 |
| CA2085464C (en) | 2002-12-17 |
| BR9106563A (pt) | 1993-06-22 |
| EP0533845A4 (en) | 1993-11-18 |
| NO924820D0 (no) | 1992-12-14 |
| ATE251750T1 (de) | 2003-10-15 |
| EP0533845A1 (en) | 1993-03-31 |
| WO1991019977A1 (en) | 1991-12-26 |
| HU9203923D0 (en) | 1993-03-29 |
| JPH06500164A (ja) | 1994-01-06 |
| KR0171393B1 (ko) | 1999-05-15 |
| WO1991019978A1 (en) | 1991-12-26 |
| FI925673A0 (fi) | 1992-12-14 |
| US5162231A (en) | 1992-11-10 |
| FI925673A (fi) | 1992-12-14 |
| NO924820L (no) | 1993-02-12 |
| HUT63499A (en) | 1993-08-30 |
| AU670743B2 (en) | 1996-08-01 |
| DE69133325D1 (de) | 2003-11-13 |
| US5391547A (en) | 1995-02-21 |
| JP3047468B2 (ja) | 2000-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0533845T3 (da) | Anvendelse af 5,10,15,20-tetrakis(r-carboxyphenyl)porphin til detektion og behandling af lungecancer | |
| RU92016479A (ru) | Применение 5,10,15,20-тетракис (4-карбоксифенил) порфина для обнаружения и лечения рака легких | |
| Spiess et al. | Bone cancers induced by 224Ra (Th X) in children and adults | |
| Hambright et al. | The distribution of various water soluble radioactive metalloporphyrins in tumor bearing mice | |
| DeRiemer et al. | BLEDTA: tumor localization by a bleomycin analog containing a metal-chelating group | |
| Carpenter et al. | Cerenkov luminescence endoscopy: improved molecular sensitivity with β−-emitting radiotracers | |
| ATE60134T1 (de) | System zur kohlenanalyse und gammastrahlendetektor. | |
| NL7600104A (nl) | Dragermateriaal voor plaatsbepaling met radio-ak- tieve isotopen in medisch onderzoek en werkwijze voor de bereiding daarvan. | |
| Celentano et al. | Preliminary tests of a prototype system for optical and radionuclide imaging in small animals | |
| de Lima | Radioisotopes in medicine | |
| Lawrence | Artificial radio-activity and neutron rays in biology and medicine | |
| Moore | Porphyrin Localisation and Treatment of Tumors | |
| Cameron et al. | A final summary of measurements of cosmogenic AI26 in stone meteorites | |
| Son | Radiation carcinogenesis | |
| Liukkonen et al. | Levels of 82Kr from the decay of 35 h 82Br | |
| Parsa et al. | Decay scheme of 2.71 h 92Sr | |
| SE7908576L (sv) | Apparat for legesbestemning av ett omrade i menniskokroppen med upptag av ett radioaktivt emne, serskilt av en ventrombos med upptag av 125 i | |
| Cole et al. | Method of using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine for detecting cancers of the lung | |
| MacDonald et al. | Short term tissue distribution of several radionuclides useful in bone scanning. | |
| Pai et al. | F-18-FDG whole body scan using gamma camera equipped with ultra high energy collimator in cancer patients: comparison with FDG coincidence PET | |
| Gottschalk | Semiannual Report to THE ATOMIC ENERGY COMMISSION. MARCH 1968 | |
| Fujiwara et al. | Triple-labeled Whole-body Autoradiography of Tumor Bearing Rat using 18F-FDG, 67Ga-Citrate and 75Se-Selenomethionine | |
| Yang et al. | “Clear Plate” Technique for Localization and Orientation in Rectilinear Scanning | |
| Dennis | The Assessment of Radioactive Contamination in Man 1984 | |
| IN652 | MANILA PHILIPPINES^ |